SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-758802
Filing Date
2016-11-03
Accepted
2016-11-03 16:03:01
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d97137d10q.htm 10-Q 683001
2 EX-10.1 d97137dex101.htm EX-10.1 17460
3 EX-10.2 d97137dex102.htm EX-10.2 40027
4 EX-31.1 d97137dex311.htm EX-31.1 8914
5 EX-31.2 d97137dex312.htm EX-31.2 8943
6 EX-32.1 d97137dex321.htm EX-32.1 3924
7 EX-32.2 d97137dex322.htm EX-32.2 3988
14 GRAPHIC g97137ex102pg01.jpg GRAPHIC 9402
15 GRAPHIC g97137tx19.jpg GRAPHIC 128987
  Complete submission text file 0001193125-16-758802.txt   3752287

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alny-20160930.xml EX-101.INS 655144
9 XBRL TAXONOMY EXTENSION SCHEMA alny-20160930.xsd EX-101.SCH 35276
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20160930_cal.xml EX-101.CAL 51554
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20160930_def.xml EX-101.DEF 208610
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20160930_lab.xml EX-101.LAB 298941
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20160930_pre.xml EX-101.PRE 236778
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 161971506
SIC: 2834 Pharmaceutical Preparations